1 BTC
=
- USD
Summit Therapeutics Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Market Statistics
Trading Metrics
How to Buy SMMT
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy SMMT
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesSuperstring Capital Management established a new $5.82 million position in Vir Biotechnology by acquiring 730,548 shares in Q1 2026. The investment appears to be a bet on upcoming clinical catalysts rather than current financials, with Vir expecting Phase 3 hepatitis delta data in Q4 2026 and pivotal Phase 3 oncology trials in 2027. Despite being unprofitable, the company has a strong balance sheet with $809.3 million in cash and runway into late 2028.
Multiple large-cap stocks experienced significant declines last week due to earnings misses and disappointing guidance. The top losers included Rambus (down 28.47%), Summit Therapeutics (down 27.82%), and Teradyne (down 17.85%), with notable declines also from Roblox, Spotify, and Robinhood. Weak financial results and lowered forward guidance across tech, fintech, and other sectors shook investor confidence.
U.S. equities reached all-time highs on Friday as Apple's blowout Q2 earnings powered a broad technology rally. The S&P 500 advanced 0.7% to 7,262, while the Nasdaq 100 rose 1.1% to 27,743. Apple surged 5.1% on strong revenue and guidance, while software stocks like Atlassian, Twilio, and Reddit soared on earnings beats. Energy stocks declined as crude oil fell over 3%. Some mega-cap earnings disappointed, including Amgen and Roblox, which posted significant declines.
A wave of momentum swept through large-cap stocks during the week of April 13-17, 2026, with ten standout performers. Notable gainers include Avis Budget Group (71.48% jump driven by short squeeze), IonQ (62.86% surge following DARPA contract award), Oklo (33.35% rise on nuclear power narrative), Robinhood (33.22% gain from bullish analyst outlook and crypto rebound), and Strategy Inc (31.86% increase). Other top performers include Tempus AI, Credo Technology, Affirm Holdings, and Summit Therapeutics, with gains ranging from 28-31%.
U.S. equities reached all-time highs on Thursday as President Trump announced a 10-day ceasefire between Israeli and Lebanese leaders. The S&P 500 advanced to 7,038.57 (+0.2%), while the Nasdaq 100 rallied 0.6% to 26,359 on its 12th straight session of gains. Oil prices surged on Iran's Hormuz toll legislation, with WTI crude jumping 2.5% to $93.58. Energy and technology sectors led gains, though healthcare stocks declined following weak guidance from Abbott Laboratories.
